Parteck® PLX 188 Excipient: Accelerate Dissolution

Poor dissolution remains a persistent barrier to bioavailability, particularly for DCS class 2a compounds. This excipient is designed to address that challenge while supporting the realities of modern solid dose manufacturing. With a defined particle size distribution and water‑soluble lubrication, it enables faster dissolution without compromising tablet hardness or process efficiency. Its functionality makes it well-suited for direct compression and continuous manufacturing, offering formulators a way to simplify formulations while maintaining consistent performance. Beyond dissolution enhancement, it can reduce reliance on traditional hydrophobic lubricants that may hinder disintegration. Comprehensive quality documentation and regulatory alignment further support risk assessment and smoother development workflows.

Explore how a single, multifunctional excipient can help streamline formulation strategies while improving drug product performance.